OTC · TAUG
Tauriga Sciences, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Aug 16, 2026, 3:45 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 3K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 5K
- Avg. volume
- 1.56K
Price performance
TAUG price history
1M range · 0 trading sessions · Daily adjusted prices
TAUG does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest TAUG news
The latest Smart Investors Daily articles mentioning TAUG.
Stock researchCompany · Overview
TAUG research
Overview
Company profile and research snapshot.
Company profile
Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
